SECsense Logo

Cognition Therapeutics, Inc. 8-K Report: Key Insights from January 13, 2025

$CGTX
Form 8-K
Filed on: 2025-01-13
Source
Cognition Therapeutics, Inc. 8-K Report: Key Insights from January 13, 2025

Based on the provided XML section from the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Cognition Therapeutics, Inc.
  • CIK (Central Index Key): 0001455365
  • IRS Employer Identification Number (EIN): 13-4365359
  • Address: 2500 Westchester Avenue, Purchase, NY 10577
  • Phone Number: 412-481-2210
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 13, 2025
  • SEC File Number: 001-40886
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: CGTX
  • Exchange: NASDAQ
  1. Context Information:
  • Reporting Date: January 13, 2025
  • Period Covered: The report covers a single day, January 13, 2025.
  1. Units and Measures:
  • The financials are reported in USD (United States Dollar) as well as shares.
  • There is a specific measure indicated for USD per share.

This section suggests that Cognition Therapeutics, Inc. has filed an 8-K report, which typically indicates that it is reporting a significant event that would be of interest to investors, though the specific details of that event are not included in this extracted portion. The emphasis on the stock's par value and the stock exchange listing indicates the company's commitment to transparency regarding its equity structure.